Boston Scientific Corporation (BSX)

Boston Scientific Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	112,542	84,691	66,273	60,534	51,478	63,029
Market Cap Growth	39.98%	27.79%	9.48%	17.59%	-18.33%	28.88%
Enterprise Value	120,832	92,928	74,280	67,674	58,887	72,820
PE Ratio	64.33	53.94	103.23	61.46	-447.63	13.41
PS Ratio	7.65	5.95	5.23	5.09	5.19	5.87
PB Ratio	5.65	4.39	3.77	3.64	3.36	4.54
P/FCF Ratio	65.13	46.38	64.97	42.87	41.82	43.95
P/OCF Ratio	45.43	33.84	43.43	32.37	34.14	34.33
EV/Sales Ratio	8.22	6.53	5.86	5.69	5.94	6.78
EV/EBITDA Ratio	33.24	26.96	27.04	26.95	41.94	33.54
EV/EBIT Ratio	49.93	41.28	46.11	47.72	209.56	62.78
EV/FCF Ratio	69.93	50.89	72.82	47.93	47.84	50.78
Debt / Equity Ratio	0.53	0.47	0.51	0.55	0.60	0.72
Debt / EBITDA Ratio	2.92	2.64	3.25	3.61	6.51	4.61
Debt / FCF Ratio	6.15	4.98	8.76	6.42	7.43	6.98
Quick Ratio	0.94	0.63	0.76	0.87	0.89	0.42
Current Ratio	1.67	1.32	1.52	1.48	1.82	0.97
Asset Turnover	0.42	0.42	0.39	0.38	0.32	0.41
Interest Coverage	8.96	8.49	3.43	4.16	0.78	2.45
Return on Equity (ROE)	9.30%	8.50%	3.70%	6.10%	-0.80%	44.50%
Return on Assets (ROA)	5.10%	4.60%	2.00%	3.10%	-0.40%	17.80%
Return on Capital (ROIC)	6.65%	6.62%	3.80%	4.51%	-0.32%	43.45%
Earnings Yield	1.57%	1.85%	0.97%	1.63%	-0.22%	7.46%
FCF Yield	1.54%	2.16%	1.54%	2.33%	2.39%	2.28%
Buyback Yield / Dilution	-2.47%	-1.65%	-0.41%	-1.21%	-0.43%	-0.66%
Total Shareholder Return	-2.47%	-1.65%	-0.41%	-1.21%	-0.43%	-0.66%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).